Thomas W. McLean

1.8k total citations
67 papers, 1.0k citations indexed

About

Thomas W. McLean is a scholar working on Pediatrics, Perinatology and Child Health, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Thomas W. McLean has authored 67 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pediatrics, Perinatology and Child Health, 18 papers in Surgery and 15 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Thomas W. McLean's work include Childhood Cancer Survivors' Quality of Life (14 papers), Vascular Malformations and Hemangiomas (8 papers) and Acute Lymphoblastic Leukemia research (7 papers). Thomas W. McLean is often cited by papers focused on Childhood Cancer Survivors' Quality of Life (14 papers), Vascular Malformations and Hemangiomas (8 papers) and Acute Lymphoblastic Leukemia research (7 papers). Thomas W. McLean collaborates with scholars based in United States, United Kingdom and Canada. Thomas W. McLean's co-authors include Allen R. Chauvenet, Kathi J. Kemper, James Lovato, Sharon M. Castellino, D. Gary Gilliland, Marcia M. Wofford, Lewis B. Silverman, Stephen E. Sallan, Richard D. Gelber and Craig A. Hamilton and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Neurology.

In The Last Decade

Thomas W. McLean

61 papers receiving 962 citations

Peers

Thomas W. McLean
Carmen Rodrı́guez Spain
Deepak Kamat United States
Samuel Lurie Israel
Thomas Schmitz France
Mirjam Kunze Germany
Mikko Arola Finland
A.G.W. Whitfield United Kingdom
Andrea Martín‐Nalda Spain
Riccardo Castagnoli Italy
Rachna Seth India
Carmen Rodrı́guez Spain
Thomas W. McLean
Citations per year, relative to Thomas W. McLean Thomas W. McLean (= 1×) peers Carmen Rodrı́guez

Countries citing papers authored by Thomas W. McLean

Since Specialization
Citations

This map shows the geographic impact of Thomas W. McLean's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas W. McLean with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas W. McLean more than expected).

Fields of papers citing papers by Thomas W. McLean

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas W. McLean. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas W. McLean. The network helps show where Thomas W. McLean may publish in the future.

Co-authorship network of co-authors of Thomas W. McLean

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas W. McLean. A scholar is included among the top collaborators of Thomas W. McLean based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas W. McLean. Thomas W. McLean is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Yip, Steven, Winson Y. Cheung, Armen Aprikian, et al.. (2025). Treatment intensification in metastatic castration-sensitive prostate cancer: a real-world study in Alberta, Canada. Future Oncology. 21(10). 1197–1207. 1 indexed citations
3.
Ekman, Simon, Florian Guisier, Cheryl Ho, et al.. (2023). 1381P TOGETHER: Pooled real-world datasets of METex14 skipping NSCLC and adjusted comparison of upfront (chemo-)immunotherapy with tepotinib from VISION. Annals of Oncology. 34. S792–S793. 3 indexed citations
4.
Borst, Alexandra J., et al.. (2023). Barriers to Genetic Testing in Vascular Malformations. JAMA Network Open. 6(5). e2314829–e2314829. 3 indexed citations
5.
Reinmuth, Niels, Sanjay Popat, Luis Paz‐Ares, et al.. (2021). 1255P Health utility with tepotinib in patients (pts) with MET exon 14 (METex14) skipping non-small cell lung cancer (NSCLC). Annals of Oncology. 32. S985–S986. 2 indexed citations
6.
Nazal, Mark R., et al.. (2021). Nontranfusional Management of Severe Anemia in an Adolescent Jehovah's Witness Patient. Journal of Adolescent Health. 69(1). 166–167.
7.
McCrory, Michael C., Sophia Wang, Avinash K. Shetty, et al.. (2018). Sudden Cardiac Arrest Due to Hemophagocytic Lymphohistiocytosis in a Child. Journal of Emergency Medicine. 55(5). e119–e123. 3 indexed citations
8.
McLean, Thomas W., et al.. (2016). Imaging of primary pediatric lymphoma of bone. Pediatric Radiology. 46(8). 1150–1157. 14 indexed citations
9.
Blatt, Julie, Thomas W. McLean, Sharon M. Castellino, & Craig N. Burkhart. (2013). A review of contemporary options for medical management of hemangiomas, other vascular tumors, and vascular malformations. Pharmacology & Therapeutics. 139(3). 327–333. 33 indexed citations
10.
Grier, David D., et al.. (2010). An unusual case of acute myeloid leukemia: Late isolated testicular relapse followed by isolated central nervous system relapse. Pediatric Blood & Cancer. 55(6). 1231–1233. 5 indexed citations
11.
Castellino, Sharon M., et al.. (2009). Pediatric genitourinary tumors. Current Opinion in Oncology. 21(3). 278–283. 21 indexed citations
12.
Kobayashi, Daisuke, Marcia M. Wofford, Thomas W. McLean, & Jen‐Jar Lin. (2009). Spontaneous tumor lysis syndrome in a child with T‐cell acute lymphoblastic leukemia. Pediatric Blood & Cancer. 54(5). 773–775. 24 indexed citations
13.
DuBois, Steven G., Antonio R. Pérez‐Atayde, Thomas W. McLean, & Holcombe E. Grier. (2008). Late Recurrence of Ewing Sarcoma During Pregnancy. Journal of Pediatric Hematology/Oncology. 30(9). 716–718. 9 indexed citations
14.
Martin, Paul L., et al.. (2006). Acute myelogenous leukemia associated with Ollier disease. Pediatric Blood & Cancer. 50(3). 645–646. 15 indexed citations
15.
McLean, Thomas W., Kelly Rouster‐Stevens, Charles R. Woods, & Avinash K. Shetty. (2005). Catheter‐related bacteremia due to Roseomonas species in pediatric hematology/oncology patients. Pediatric Blood & Cancer. 46(4). 514–516. 18 indexed citations
16.
Spangler, John G., et al.. (2003). Religiosity is Associated With the Use of Complementary Medical Therapies by Pediatric Oncology Patients. Journal of Pediatric Hematology/Oncology. 25(2). 125–129. 84 indexed citations
17.
McLean, Thomas W.. (2003). Medulloblastomas and central nervous system primitive neuroectodermal tumors. Current Treatment Options in Oncology. 4(6). 499–508. 8 indexed citations
18.
McLean, Thomas W., Mary Lynn Young, Karen Marcus, et al.. (1999). Late Events in Pediatric Patients With Ewing Sarcoma/Primitive Neuroectodermal Tumor of Bone. Journal of Pediatric Hematology/Oncology. 21(6). 486–493. 41 indexed citations
19.
Loh, Mignon L., et al.. (1998). Lack of TEL/AML1 fusion in pediatric AML: further evidence for lineage specificity of TEL/AML1. Leukemia Research. 22(5). 461–464. 10 indexed citations
20.
Silverman, Lewis B., Thomas W. McLean, Richard D. Gelber, et al.. (1997). Intensified therapy for infants with acute lymphoblastic leukemia: results from the Dana-Farber Cancer Institute Consortium.. PubMed. 80(12). 2285–95. 81 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carmen Rodrı́guez Breakdown of academic impact, for papers by Deepak Kamat Breakdown of academic impact, for papers by Samuel Lurie Breakdown of academic impact, for papers by Thomas Schmitz Breakdown of academic impact, for papers by Mirjam Kunze Breakdown of academic impact, for papers by Mikko Arola Breakdown of academic impact, for papers by A.G.W. Whitfield Breakdown of academic impact, for papers by Andrea Martín‐Nalda Breakdown of academic impact, for papers by Riccardo Castagnoli Breakdown of academic impact, for papers by Rachna Seth
Rankless by CCL
2026